Normunity
Vivian Gu is a Scientist at Normunity since July 2023, bringing extensive experience in cancer research and biotechnology. Prior to this role, Vivian served as a Postdoctoral Fellow at the Yale University School of Medicine, where investigations focused on the biological pathways of immune cells and platelets in breast cancer, as well as the epigenetic regulation of obesity. Vivian also held roles as a Blavatnik Associate and Y-AID Fellow at Yale Ventures, where responsibilities included market research and strategic planning for early-stage ventures. Academic qualifications include a PhD in Oncology and Cancer Biology from the University of Iowa and a postdoctoral fellowship in Cardiovascular Science at Yale School of Medicine, complemented by a Bachelor of Science in Biochemistry from the University of Iowa.
This person is not in any teams
This person is not in any offices
Normunity
1 followers
Normunity is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer.Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targetingnewly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer.Normunity is located in Boston, Massachusetts and West Haven, Connecticut.